Literature DB >> 23748887

Anxiety and depression in the general population in Colombia: reference values of the Hospital Anxiety and Depression Scale (HADS).

Andreas Hinz1, Carolyn Finck, Yvonne Gómez, Isolde Daig, Heide Glaesmer, Susanne Singer.   

Abstract

PURPOSE: The objective of this study was to generate normative values and to test psychometric properties of the Hospital Anxiety and Depression Scale (HADS) for the general population of Colombia. While there are several normative studies in Europe, Latin American normative values are missing. The identification of people with mental distress requires norms obtained for the specific country.
METHODS: A representative face-to-face household study (n = 1,500) was conducted in 2012. The survey questionnaire contained the HADS, several other questionnaires, and sociodemographic variables.
RESULTS: HADS mean values (anxiety: M = 4.61 ± 3.64, depression: M = 4.30 ± 3.91) were similar to those reported from European studies. Females were more anxious and depressed than males. The depression scale showed a nearly linear age dependency with increasing scores for old people. Mean scores and percentiles (75 and 90%) are presented for each age decade for both genders. Both anxiety and depression correlated significantly with the total score of the multidimensional fatigue inventory and with the mental component summary score of the quality of life questionnaire SF-8. Internal consistency coefficients of both scales were satisfying, but confirmatory factorial analysis results only partially supported the two-dimensional structure of the questionnaire.
CONCLUSION: This study supports the reliability of the HADS in one Latin American country. The normative scores can be used to compare a patient's score with those derived from a reference group. However, the generalizability to other Latin American regions requires further research.

Entities:  

Mesh:

Year:  2013        PMID: 23748887     DOI: 10.1007/s00127-013-0714-y

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  36 in total

1.  Quality of life in Brazil: normative values for the WHOQOL-bref in a southern general population sample.

Authors:  Luciane N Cruz; Carisi A Polanczyk; Suzi A Camey; Juliana F Hoffmann; Marcelo P Fleck
Journal:  Qual Life Res       Date:  2011-01-29       Impact factor: 4.147

2.  Are men more depressed than women in Norway? Validity of the Hospital Anxiety and Depression Scale.

Authors:  Monica W Nortvedt; Trond Riise; Bjarte Sanne
Journal:  J Psychosom Res       Date:  2006-02       Impact factor: 3.006

3.  Estimating the SF-6D value set for a population-based sample of Brazilians.

Authors:  Luciane N Cruz; Suzi A Camey; Juliana F Hoffmann; Donna Rowen; John E Brazier; Marcelo P Fleck; Carisi A Polanczyk
Journal:  Value Health       Date:  2011 Jul-Aug       Impact factor: 5.725

4.  Normative values for the hospital anxiety and depression scale (HADS) in the general German population.

Authors:  Andreas Hinz; Elmar Brähler
Journal:  J Psychosom Res       Date:  2011-03-02       Impact factor: 3.006

5.  Three-dimensional structure of the Hospital Anxiety and Depression Scale in a large French primary care population suffering from major depression.

Authors:  S Friedman; J C Samuelian; S Lancrenon; C Even; P Chiarelli
Journal:  Psychiatry Res       Date:  2001-11-30       Impact factor: 3.222

6.  A confirmatory factor analysis of the Hospital Anxiety and Depression scale: comparing empirically and theoretically derived structures.

Authors:  M Dunbar; G Ford; K Hunt; G Der
Journal:  Br J Clin Psychol       Date:  2000-03

7.  Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale.

Authors:  A B Smith; E P Wright; R Rush; D P Stark; G Velikova; P J Selby
Journal:  Psychooncology       Date:  2006-09       Impact factor: 3.894

8.  Normative data for the HADS from a large non-clinical sample.

Authors:  J R Crawford; J D Henry; C Crombie; E P Taylor
Journal:  Br J Clin Psychol       Date:  2001-11

9.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

10.  How does the Hospital and Anxiety and Depression Scale measure anxiety and depression in healthy subjects?

Authors:  Hervé Caci; Franck J Baylé; Vianney Mattei; Christelle Dossios; Philippe Robert; Patrice Boyer
Journal:  Psychiatry Res       Date:  2003-05-01       Impact factor: 3.222

View more
  14 in total

1.  Anxiety and depression analyses of patients undergoing diagnostic cystoscopy.

Authors:  Stephan Seklehner; Paul Friedrich Engelhardt; Mesut Remzi; Harun Fajkovic; Zana Saratlija-Novakovic; Matthias Skopek; Irene Resch; Mario Duvnjak; Stephan Hruby; Clemens Wehrberger; Davor Librenjak; Wilhelm Hübner; Eckart Breinl; Claus Riedl
Journal:  Qual Life Res       Date:  2016-03-17       Impact factor: 4.147

2.  Tailoring Cognitive Behavioral Therapy for Depression and Anxiety Symptoms in Mexican Terminal Cancer Patients: A Multiple Baseline Study.

Authors:  Edgar Landa-Ramírez; Joseph A Greer; Sofía Sánchez-Román; Rumen Manolov; Ma Magdalena Salado-Avila; Luz Adriana Templos-Esteban; Angélica Riveros-Rosas
Journal:  J Clin Psychol Med Settings       Date:  2020-03

3.  Radix Bupleuri ameliorates depression by increasing nerve growth factor and brain-derived neurotrophic factor.

Authors:  Xia Wang; Qing Feng; Yong Xiao; Ping Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  The impacts of a GO-game (Chinese chess) intervention on Alzheimer disease in a Northeast Chinese population.

Authors:  Qiao Lin; Yunpeng Cao; Jie Gao
Journal:  Front Aging Neurosci       Date:  2015-08-25       Impact factor: 5.750

5.  A confirmatory bifactor analysis of the Hospital Anxiety and Depression Scale in an Italian community sample.

Authors:  Luca Iani; Marco Lauriola; Massimo Costantini
Journal:  Health Qual Life Outcomes       Date:  2014-06-05       Impact factor: 3.186

6.  Decreased expression of the APOA1-APOC3-APOA4 gene cluster is associated with risk of Alzheimer's disease.

Authors:  Qiao Lin; Yunpeng Cao; Jie Gao
Journal:  Drug Des Devel Ther       Date:  2015-09-29       Impact factor: 4.162

7.  Standardization of the Colombian version of the PHQ-4 in the general population.

Authors:  Rüya-Daniela Kocalevent; Carolyn Finck; William Jimenez-Leal; Leon Sautier; Andreas Hinz
Journal:  BMC Psychiatry       Date:  2014-07-19       Impact factor: 3.630

8.  No Association of BDNF, COMT, MAOA, SLC6A3, and SLC6A4 Genes and Depressive Symptoms in a Sample of Healthy Colombian Subjects.

Authors:  Yeimy González-Giraldo; Andrés Camargo; Sandra López-León; Diego A Forero
Journal:  Depress Res Treat       Date:  2015-10-08

9.  Personality traits and health-related quality of life: the mediator role of coping strategies and psychological distress.

Authors:  Angela J Pereira-Morales; Ana Adan; Sandra Lopez-Leon; Diego A Forero
Journal:  Ann Gen Psychiatry       Date:  2018-06-06       Impact factor: 3.455

10.  Depressive symptoms are associated with a functional polymorphism in a miR-433 binding site in the FGF20 gene.

Authors:  Karen M Jiménez; Angela J Pereira-Morales; Ana Adan; Sandra Lopez-Leon; Diego A Forero
Journal:  Mol Brain       Date:  2018-09-21       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.